Company / PP&E (Net)
Marker Therapeutics, Inc. PP&E (Net) History
FY2018-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$12.3M
FY2021
5-year range
$147.7K / $12.3M
FY2018-FY2021
Trend
+2848.1%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) changed +2848% YoY in FY2021, a notable deviation from the 2-year average annual change of +1516%.
Based on SEC 10-K filings.
$12M in FY2021.
Improved from $147,668 to $12M over the past 3 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +337.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +337.0%, indicating consistent growth.
- In FY2021, pp&e (net) increased 2848.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2021 | $12.3M | +2848.1% |
| FY2019 | $418.0K | +183.1% |
| FY2018 | $147.7K | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026